MGA Holding

MGA Holding is a prominent Turkish conglomerate that operates as the parent company for Nobel İlaç, a leading international pharmaceutical player. The holding company manages a comprehensive value chain in the life sciences sector, including raw material synthesis through Ulkar Kimya and advanced pharmaceutical research via its Fargem R&D center. MGA Holding's primary focus is on the development, manufacturing, and marketing of a diverse range of pharmaceutical products, with a strategic emphasis on expanding its biotechnological and biosimilar portfolio. Through Nobel İlaç, the group maintains a strong commercial presence in over 20 countries with its own organizations and exports to more than 50 countries globally. The company is recognized for launching Turkey's first locally produced biosimilar, reflecting its commitment to high-tech pharmaceutical manufacturing.